GLP1R and pancreatic insulinoma: Although metastatic insulinomas often seem to lack GLP-1R expression, and non-metastatic insulinomas can usually be removed surgically, the GLP-1R-targeted radionuclide therapy could become a novel treatment strategy for patients with a GLP-1R-positive insulinoma, when curative surgery in not an option.